Future perspectives: Should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation?

Cancer Immunology, Immunotherapy

Volumn 60, Issue 12, 2011, Pages 1669-1681

  Ersvær, Elisabeth ^a,b,c   Melve, Guro Kristin ^c   Bruserud, Øystein ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b BERGEN UNIVERSITY COLLEGE   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute myelogenous leukemia; Allogeneic stem cell transplantation; Interleukin 17; Peripheral blood stem cell mobilization; Th17 cells

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CELL FUNCTION; CELL TRACKING; CYTOKINE RELEASE; GRAFT VERSUS HOST REACTION; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PATIENT SELECTION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; TH17 CELL; TUMOR MICROENVIRONMENT;

ANIMALS; CELL DIFFERENTIATION; CHEMOTAXIS, LEUKOCYTE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; SIGNAL TRANSDUCTION; TH17 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 82355181052     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1118-z     Document Type: Review

References (93)

1. O Stutman 1986 Postthymic T-cell development Immunol Rev 91 159 194 3525393 10.1111/j.1600-065X.1986.tb01488.x 1:STN:280:DyaL283ns1Kisw%3D%3D (Pubitemid 16070603)
2. + CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease J Immunol 185 7 3866 3872 10.4049/jimmunol.1001625 20810991 10.4049/jimmunol.1001625 1:CAS:528:DC%2BC3cXhtFyisrrE
3. P Reddy Y Maeda C Liu OI Krijanovski R Korngold JL Ferrara 2005 A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses Nat Med 11 11 1244 1249 10.1038/nm1309 16227991 10.1038/nm1309 1:CAS:528:DC%2BD2MXhtFOhsLrE (Pubitemid 43093673)
4. S Paczesny D Hanauer Y Sun P Reddy 2010 New perspectives on the biology of acute GVHD Bone Marrow Transplant 45 1 1 11 10.1038/bmt.2009.328 19946340 10.1038/bmt.2009.328 1:STN:280:DC%2BC3c%2FitVWitg%3D%3D
5. JM Li CR Giver Y Lu MS Hossain M Akhtari EK Waller 2009 Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation Immunotherapy 1 4 599 621 20191089 1:CAS:528:DC%2BD1MXhtVygsrzE
6. H Park Z Li XO Yang SH Chang R Nurieva YH Wang Y Wang L Hood Z Zhu Q Tian C Dong 2005 A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Nat Immunol 6 11 1133 1141 10.1038/ni1261 16200068 10.1038/ni1261 1:CAS:528:DC%2BD2MXhtFamsb%2FO (Pubitemid 41541791)
7. F Annunziato S Romagnani 2010 The transient nature of the Th17 phenotype Eur J Immunol 40 12 3312 3316 10.1002/eji.201041145 21110314 10.1002/eji.201041145 1:CAS:528:DC%2BC3cXhsVOktbnN
8. MA Kleinschek K Boniface S Sadekova J Grein EE Murphy SP Turner L Raskin B Desai WA Faubion R de Waal Malefyt RH Pierce T McClanahan RA Kastelein 2009 Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation J Exp Med 206 3 525 534 10.1084/jem.20081712 19273624 10.1084/jem.20081712 1:CAS:528:DC%2BD1MXjsVaisLc%3D
9. L Maggi V Santarlasci M Capone A Peired F Frosali SQ Crome V Querci M Fambrini F Liotta MK Levings E Maggi L Cosmi S Romagnani F Annunziato 2010 CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC Eur J Immunol 40 8 2174 2181 10.1002/eji.200940257 20486123 10.1002/eji. 200940257 1:CAS:528:DC%2BC3cXpsF2rtro%3D
10. + T cell precursor J Exp Med 205 8 1903 1916 10.1084/jem.20080397 18663128 10.1084/jem.20080397 1:CAS:528:DC%2BD1cXpsFOjsbg%3D
11. AC Melton SL Bailey-Bucktrout MA Travis BT Fife JA Bluestone D Sheppard 2010 Expression of alphavbeta8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice J Clin Invest 120 12 4436 4444 10.1172/JCI43786 21099117 10.1172/JCI43786 1:CAS:528: DC%2BC3cXhsFCntLjM
12. A Kimura T Kishimoto 2010 IL-6: regulator of Treg/Th17 balance Eur J Immunol 40 7 1830 1835 10.1002/eji.201040391 20583029 10.1002/eji.201040391 1:CAS:528:DC%2BC3cXotVOkurc%3D
13. T Korn E Bettelli W Gao A Awasthi A Jager TB Strom M Oukka VK Kuchroo 2007 IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells Nature 448 7152 484 487 10.1038/nature05970 17581588 10.1038/nature05970 1:CAS:528:DC%2BD2sXotFajurw%3D (Pubitemid 47123515)
14. L Yang DE Anderson C Baecher-Allan WD Hastings E Bettelli M Oukka VK Kuchroo DA Hafler 2008 IL-21 and TGF-beta are required for differentiation of human T(H)17 cells Nature 454 7202 350 352 10.1038/nature07021 18469800 10.1038/nature07021 1:CAS:528:DC%2BD1cXosFCqs7o%3D
15. K Ghoreschi A Laurence XP Yang CM Tato MJ McGeachy JE Konkel HL Ramos L Wei TS Davidson N Bouladoux JR Grainger Q Chen Y Kanno WT Watford HW Sun G Eberl EM Shevach Y Belkaid DJ Cua W Chen JJ O'Shea 2010 Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling Nature 467 7318 967 971 10.1038/nature09447 20962846 10.1038/nature09447 1:CAS:528:DC%2BC3cXhtlWmu7vI
16. EV Acosta-Rodriguez G Napolitani A Lanzavecchia F Sallusto 2007 Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells Nat Immunol 8 9 942 949 10.1038/ni1496 17676045 10.1038/ni1496 1:CAS:528: DC%2BD2sXptlSku7w%3D (Pubitemid 47300008)
17. V Santarlasci L Maggi M Capone F Frosali V Querci R De Palma F Liotta L Cosmi E Maggi S Romagnani F Annunziato 2009 TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells Eur J Immunol 39 1 207 215 10.1002/eji.200838748 19130583 10.1002/eji.200838748 1:CAS:528: DC%2BD1MXhs1SiurY%3D
18. D Valmori C Raffin I Raimbaud M Ayyoub 2010 Human RORgammat + TH17 cells preferentially differentiate from naive FOXP3 + Treg in the presence of lineage-specific polarizing factors Proc Natl Acad Sci USA 107 45 19402 19407 10.1073/pnas.1008247107 20962281 10.1073/pnas.1008247107 1:CAS:528: DC%2BC3cXhsVGltr%2FL
19. IA Silva K Olkiewicz D Askew JM Fisher MN Chaudhary KM Vannella DT Deurloo SW Choi EM Pierce SG Clouthier C Liu KR Cooke 2010 Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activation Biol Blood Marrow Transplant 16 5 598 611 10.1016/j.bbmt.2009.12.007 20117226 10.1016/j.bbmt.2009.12.007
20. K Hirahara K Ghoreschi A Laurence XP Yang Y Kanno JJ O'Shea 2010 Signal transduction pathways and transcriptional regulation in Th17 cell differentiation Cytokine Growth Factor Rev 21 6 425 434 10.1016/j.cytogfr.2010. 10.006 21084214 10.1016/j.cytogfr.2010.10.006 1:CAS:528:DC%2BC3cXhsFant7rJ
21. II Ivanov BS McKenzie L Zhou CE Tadokoro A Lepelley JJ Lafaille DJ Cua DR Littman 2006 The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells Cell 126 6 1121 1133 10.1016/j.cell.2006.07.035 16990136 10.1016/j.cell.2006.07.035 1:CAS:528:DC%2BD28XhtVCnsrrE (Pubitemid 44380299)
22. SL Masters LA Mielke AL Cornish CE Sutton J O'Donnell LH Cengia AW Roberts IP Wicks KH Mills BA Croker 2010 Regulation of interleukin-1beta by interferon-gamma is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production EMBO Rep 11 8 640 646 10.1038/embor.2010.93 20596075 10.1038/embor.2010.93 1:CAS:528: DC%2BC3cXotlWkurY%3D
23. MH Lexberg A Taubner I Albrecht I Lepenies A Richter T Kamradt A Radbruch HD Chang 2010 IFN-gamma and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells Eur J Immunol 40 11 3017 3027 10.1002/eji.201040539 21061434 10.1002/eji.201040539 1:CAS:528:DC%2BC3cXhtl2isbnI
24. VS Ramgolam Y Sha J Jin X Zhang S Markovic-Plese 2009 IFN-beta inhibits human Th17 cell differentiation J Immunol 183 8 5418 5427 10.4049/jimmunol. 0803227 19783688 10.4049/jimmunol.0803227 1:CAS:528:DC%2BD1MXht1WhsbfI
25. C Chizzolini R Chicheportiche M Alvarez C de Rham P Roux-Lombard S Ferrari-Lacraz JM Dayer 2008 Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion Blood 112 9 3696 3703 10.1182/blood-2008-05-155408 18698005 10.1182/blood-2008-05-155408 1:CAS:528:DC%2BD1cXhtlCntrvL
26. K Boniface KS Bak-Jensen Y Li WM Blumenschein MJ McGeachy TK McClanahan BS McKenzie RA Kastelein DJ Cua R de Waal Malefyt 2009 Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling J Exp Med 206 3 535 548 10.1084/jem.20082293 19273625 10.1084/jem.20082293 1:CAS:528:DC%2BD1MXjsVaisb4%3D
27. F Annunziato L Cosmi V Santarlasci L Maggi F Liotta B Mazzinghi E Parente L Fili S Ferri F Frosali F Giudici P Romagnani P Parronchi F Tonelli E Maggi S Romagnani 2007 Phenotypic and functional features of human Th17 cells J Exp Med 204 8 1849 1861 10.1084/jem.20070663 17635957 10.1084/jem.20070663 1:CAS:528:DC%2BD2sXptVyjsLs%3D (Pubitemid 47240944)
28. NJ Wilson K Boniface JR Chan BS McKenzie WM Blumenschein JD Mattson B Basham K Smith T Chen F Morel JC Lecron RA Kastelein DJ Cua TK McClanahan EP Bowman R de Waal Malefyt 2007 Development, cytokine profile and function of human interleukin 17-producing helper T cells Nat Immunol 8 9 950 957 10.1038/ni1497 17676044 10.1038/ni1497 1:CAS:528:DC%2BD2sXptlSku7o%3D (Pubitemid 47300009)
29. N Glenjen R Hovland L Wergeland O Wendelbo P Ernst O Bruserud 2003 The angioregulatory phenotype of native human acute myelogenous leukemia cells: influence of karyotype, Flt3 abnormalities and differentiation status Eur J Haematol 71 3 163 173 12930316 10.1034/j.1600-0609.2003.00130.x 1:CAS:528:DC%2BD3sXnvVKitbg%3D (Pubitemid 37082838)
30. FC Kurschus AL Croxford AP Heinen S Wortge D Ielo A Waisman 2010 Genetic proof for the transient nature of the Th17 phenotype Eur J Immunol 40 12 3336 3346 10.1002/eji.201040755 21110317 10.1002/eji.201040755 1:CAS:528: DC%2BC3cXhsVOkur7O
31. Bruserud O (2010) The chemokine system in experimental and clinical hematology. Preface Curr Top Microbiol Immunol 341:v-vi
32. I Comerford M Bunting K Fenix S Haylock-Jacobs W Litchfield Y Harata-Lee M Turvey J Brazzatti C Gregor P Nguyen E Kara SR McColl 2010 An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation? CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease Bioessays 32 12 1067 1076 10.1002/bies.201000063 20954179 10.1002/bies.201000063 1:CAS:528:DC%2BC3MXjslamsA%3D%3D
33. SP Singh HH Zhang JF Foley MN Hedrick JM Farber 2008 Human T cells that are able to produce IL-17 express the chemokine receptor CCR6 J Immunol 180 1 214 221 18097022 1:CAS:528:DC%2BD2sXhsVGjtbvI
34. HW Lim J Lee P Hillsamer CH Kim 2008 Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells J Immunol 180 1 122 129 18097011 1:CAS:528:DC%2BD2sXhsVGjtbzJ
35. O Bruserud A Ryningen AM Olsnes L Stordrange AM Oyan KH Kalland BT Gjertsen 2007 Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells Haematologica 92 3 332 341 17339182 10.3324/haematol.10148 1:CAS:528:DC%2BD2sXhtFGqu77J (Pubitemid 350143542)
36. + T-cell-mediated acute graft-versus-host disease responses Blood 106 1 18 26 10.1182/blood-2004-08-2996 15774622 10.1182/blood-2004-08-2996 1:CAS:528:DC%2BD2MXlvVWjsrc%3D (Pubitemid 40967169)
37. M Kleinewietfeld F Puentes G Borsellino L Battistini O Rotzschke K Falk 2005 CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset Blood 105 7 2877 2886 10.1182/blood-2004-07-2505 15613550 10.1182/blood-2004-07-2505 1:CAS:528:DC%2BD2MXivFGmtLo%3D (Pubitemid 40446282)
38. O Bruserud 1999 Acute myelogenous leukemia blasts as accessory cells during T lymphocyte activation: possible implications for future therapeutic strategies Leukemia 13 8 1175 1187 10450745 10.1038/sj.leu.2401452 1:CAS:528:DyaK1MXlvVOiurw%3D (Pubitemid 29396577)
39. FL Liu CH Chen SJ Chu JH Chen JH Lai HK Sytwu DM Chang 2007 Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway Rheumatology (Oxford) 46 8 1266 1273 10.1093/rheumatology/kem055 10.1093/rheumatology/kem055 1:CAS:528:DC%2BD2sXos12iur0%3D (Pubitemid 47244499)
40. HR Kim ML Cho KW Kim JY Juhn SY Hwang CH Yoon SH Park SH Lee HY Kim 2007 Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways Rheumatology (Oxford) 46 1 57 64 10.1093/rheumatology/kel159 10.1093/rheumatology/kel159 1:CAS:528:DC%2BD28XhtlChtbbM (Pubitemid 44932784)
41. E Ersvaer AM Olsnes O Bruserud 2007 The immunological dilemma: cellular innate and adaptive immune response versus human acute myeloid leukemia Open Hematol Rev 1 1 14 1:CAS:528:DC%2BD2sXhtl2rtrfN
42. D Behl LF Porrata SN Markovic L Letendre RK Pruthi CC Hook A Tefferi MA Elliot SH Kaufmann RA Mesa MR Litzow 2006 Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia Leukemia 20 1 29 34 16281063 10.1038/sj.leu.2404032 1:STN:280:DC%2BD283hvFWgtw%3D%3D
43. LF Porrata MR Litzow A Tefferi L Letendre S Kumar SM Geyer SN Markovic 2002 Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia Leukemia 16 7 1311 1318 12094255 10.1038/sj.leu.2402503 1:STN:280:DC%2BD38znt1yksg%3D%3D
44. R Parkman G Cohen SL Carter KI Weinberg B Masinsin E Guinan J Kurtzberg JE Wagner NA Kernan 2006 Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation Biol Blood Marrow Transplant 12 9 919 927 10.1016/j.bbmt.2006. 05.008 16920557 10.1016/j.bbmt.2006.05.008
45. DH Kim SK Sohn DI Won NY Lee JS Suh KB Lee 2006 Rapid helper T-cell recovery above 200 × 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation Bone Marrow Transplant 37 12 1119 1128 10.1038/sj.bmt.1705381 16699530 10.1038/sj.bmt. 1705381 1:STN:280:DC%2BD28zktlSktA%3D%3D (Pubitemid 43871522)
46. KM Williams FT Hakim RE Gress 2007 T cell immune reconstitution following lymphodepletion Semin Immunol 19 5 318 330 10.1016/j.smim.2007.10.004 18023361 10.1016/j.smim.2007.10.004 1:CAS:528:DC%2BD2sXhtlyrurbF (Pubitemid 350181530)
47. JJ Auletta HM Lazarus 2005 Immune restoration following hematopoietic stem cell transplantation: an evolving target Bone Marrow Transplant 35 9 835 857 10.1038/sj.bmt.1704966 15778723 10.1038/sj.bmt.1704966 1:STN:280: DC%2BD2M3js1ejtA%3D%3D (Pubitemid 40667627)
48. M Obeid A Tesniere T Panaretakis R Tufi N Joza P van Endert F Ghiringhelli L Apetoh N Chaput C Flament E Ullrich S de Botton L Zitvogel G Kroemer 2007 Ecto-calreticulin in immunogenic chemotherapy Immunol Rev 220 22 34 10.1111/j.1600-065X.2007.00567.x 17979837 10.1111/j.1600-065X.2007.00567.x 1:CAS:528:DC%2BD2sXhsVKgtr3P (Pubitemid 350045569)
49. H Fredly E Ersvaer BT Gjertsen O Bruserud 2011 Immunogenic apoptosis in human acute myeloid leukemia (AML): primary human AML cells expose calreticulin and release heat shock protein (HSP) 70 and HSP90 during apoptosis Oncol Rep 25 6 1549 1556 10.3892/or.2011.1229 21431284
50. K Liseth E Ersvaer T Hervig O Bruserud 2010 Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience J Biomed Biotechnol 2010 692097 10.1155/2010/692097 20625438 10.1155/2010/692097
51. MJ Szczepanski M Szajnik M Czystowska M Mandapathil L Strauss A Welsh KA Foon TL Whiteside M Boyiadzis 2009 Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia Clin Cancer Res 15 10 3325 3332 10.1158/1078-0432.CCR-08-3010 19417016 10.1158/1078-0432.CCR-08- 3010 1:CAS:528:DC%2BD1MXmtVKmurg%3D
52. X Wang J Zheng J Liu J Yao Y He X Li J Yu J Yang Z Liu S Huang 2005 Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients Eur J Haematol 75 6 468 476 10.1111/j.1600-0609.2005.00537.x 16313258 10.1111/j.1600-0609.2005.00537.x (Pubitemid 41687780)
53. E Ersvaer K Liseth J Skavland BT Gjertsen O Bruserud 2010 Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells BMC Immunol 11 38 10.1186/1471-2172-11-38 20618967 10.1186/1471-2172-11-38
54. CG Kanakry AD Hess CD Gocke C Thoburn F Kos C Meyer J Briel L Luznik BD Smith H Levitsky JE Karp 2011 Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells Blood 117 2 608 617 10.1182/blood-2010-04-277939 20935254 10.1182/blood-2010-04-277939 1:CAS:528:DC%2BC3MXht1aqtrg%3D
55. C Wu S Wang F Wang Q Chen S Peng Y Zhang J Qian J Jin H Xu 2009 Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia Clin Exp Immunol 158 2 199 204 10.1111/j.1365-2249.2009. 04011.x 19737137 10.1111/j.1365-2249.2009.04011.x 1:CAS:528:DC%2BD1MXhtlKrurrJ
56. AK Burnett K Wheatley AH Goldstone RF Stevens IM Hann JH Rees G Harrison 2002 The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial Br J Haematol 118 2 385 400 12139722 10.1046/j.1365-2141.2002.03724.x (Pubitemid 34994639)
57. A Burnett M Wetzler B Lowenberg 2011 Therapeutic advances in acute myeloid leukemia J Clin Oncol 29 5 487 494 10.1200/JCO.2010.30.1820 21220605 10.1200/JCO.2010.30.1820
58. RP Gale MM Bortin DW van Bekkum JC Biggs KA Dicke E Gluckman RA Good RG Hoffmann HE Kay JH Kersey, et al. 1987 Risk factors for acute graft-versus-host disease Br J Haematol 67 4 397 406 3322360 10.1111/j.1365-2141.1987.tb06160.x 1:STN:280:DyaL1c7gslCntA%3D%3D (Pubitemid 18032036)
59. A Chaidos E Kanfer JF Apperley 2007 Risk assessment in haemotopoietic stem cell transplantation: disease and disease stage Best Pract Res Clin Haematol 20 2 125 154 10.1016/j.beha.2006.10.003 17448953 10.1016/j.beha.2006. 10.003 (Pubitemid 46585973)
60. B Lowenberg WL van Putten A Ferrant G Ossenkoppele E Vellenga LF Verdonck A Gratwohl MA Boogaerts 1997 Peripheral blood progenitor cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia Stem Cells 15 Suppl 1 177 180 10.1002/stem.5530150823 9368339 10.1002/stem.5530150823 discussion 181
61. P Anderlini M Korbling 1997 The use of mobilized peripheral blood stem cells from normal donors for allografting Stem Cells 15 1 9 17 10.1002/stem.150009 9007218 10.1002/stem.150009 1:STN:280:DyaK2s7lvFOjsA%3D%3D (Pubitemid 27057076)
62. M Korbling P Anderlini 2001 Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood 98 10 2900 2908 11698269 10.1182/blood.V98.10.2900 1:CAS:528: DC%2BD3MXosFynsrs%3D
63. EM Sloand S Kim JP Maciejewski F Van Rhee A Chaudhuri J Barrett NS Young 2000 Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo Blood 95 7 2269 2274 10733495 1:CAS:528:DC%2BD3cXitFeitrg%3D (Pubitemid 30167724)
64. GR Hill SD Olver RD Kuns A Varelias NC Raffelt AL Don KA Markey YA Wilson MJ Smyth Y Iwakura J Tocker AD Clouston KP Macdonald 2010 Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma Blood 116 5 819 828 10.1182/blood-2009-11-256495 20435882 10.1182/blood-2009- 11-256495 1:CAS:528:DC%2BC3cXhtVCku73K
65. LX Sun HY Ren YJ Shi LH Wang ZX Qiu 2009 Recombinant human granulocyte colony-stimulating factor significantly decreases the expression of CXCR3 and CCR6 on T cells and preferentially induces T helper cells to a T helper 17 phenotype in peripheral blood harvests Biol Blood Marrow Transplant 15 7 835 843 10.1016/j.bbmt.2009.03.016 19539215 10.1016/j.bbmt.2009.03.016 1:CAS:528:DC%2BD1MXos1OjtLs%3D
66. HC Toh L Sun Y Soe Y Wu YP Phoon WK Chia J Wu KY Wong P Tan 2009 G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo Clin Immunol 132 1 83 92 10.1016/j.clim.2009.03.509 19345152 10.1016/j.clim.2009.03.509 1:CAS:528:DC%2BD1MXmvFyrtLw%3D
67. XY Zhao LL Xu SY Lu XJ Huang 2011 IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation Eur J Immunol 41 2 514 526 10.1002/eji.201040793 21268020 10.1002/eji.201040793 1:CAS:528:DC%2BC3MXpvFCisg%3D%3D
68. K Boniface WM Blumenschein K Brovont-Porth MJ McGeachy B Basham B Desai R Pierce TK McClanahan S Sadekova R de Waal Malefyt 2010 Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage J Immunol 185 1 679 687 10.4049/jimmunol. 1000366 20511558 10.4049/jimmunol.1000366 1:CAS:528:DC%2BC3cXns1Cqt70%3D
69. EV Acosta-Rodriguez L Rivino J Geginat D Jarrossay M Gattorno A Lanzavecchia F Sallusto G Napolitani 2007 Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells Nat Immunol 8 6 639 646 10.1038/ni1467 17486092 10.1038/ni1467 1:CAS:528: DC%2BD2sXlsVSrsLo%3D (Pubitemid 46785128)
70. C Iclozan Y Yu C Liu Y Liang T Yi C Anasetti XZ Yu 2010 T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease Biol Blood Marrow Transplant 16 2 170 178 10.1016/j.bbmt.2009.09.023 19804837 10.1016/j.bbmt.2009.09.023 1:CAS:528:DC%2BC3cXjt1GmsL4%3D
71. MJ Carlson ML West JM Coghill A Panoskaltsis-Mortari BR Blazar JS Serody 2009 In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations Blood 113 6 1365 1374 10.1182/blood-2008-06-162420 18957685 10.1182/blood-2008-06-162420 1:CAS:528:DC%2BD1MXitV2ru7k%3D
72. X Chen S Vodanovic-Jankovic B Johnson M Keller R Komorowski WR Drobyski 2007 Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease Blood 110 10 3804 3813 10.1182/blood-2007-05-091074 17693581 10.1182/blood-2007-05- 091074 1:CAS:528:DC%2BD2sXhtlarurjL (Pubitemid 350159652)
73. T Yi D Zhao CL Lin C Zhang Y Chen I Todorov T LeBon F Kandeel S Forman D Zeng 2008 Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease Blood 112 5 2101 2110 10.1182/blood-2007-12-126987 18596226 10.1182/blood-2007-12-126987 1:CAS:528:DC%2BD1cXhtVyksrzO
74. WJ Murphy LA Welniak DD Taub RH Wiltrout PA Taylor DA Vallera M Kopf H Young DL Longo BR Blazar 1998 Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice J Clin Invest 102 9 1742 1748 10.1172/JCI3906 9802888 10.1172/JCI3906 1:CAS:528:DyaK1cXnt1Oqt7g%3D (Pubitemid 28516259)
75. YG Yang BR Dey JJ Sergio DA Pearson M Sykes 1998 Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12 J Clin Invest 102 12 2126 2135 10.1172/JCI4992 9854048 10.1172/JCI4992 1:CAS:528:DyaK1MXmtFOj (Pubitemid 29018819)
76. A Carvalho C Cunha M Di Ianni L Pitzurra T Aloisi F Falzetti A Carotti F Bistoni F Aversa L Romani 2010 Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation Bone Marrow Transplant 45 11 1645 1652 10.1038/bmt.2010.28 20173782 10.1038/bmt.2010.28 1:CAS:528:DC%2BC3cXhtl2gurvM
77. K Liseth M Sjo K Paulsen O Bruserud E Ersvaer 2010 Early pre-engraftment, functional, in vitro responsiveness of T lymphocytes in allotransplanted, acute leukemia patients: proliferation and release of a broad profile of cytokines, possibly predictive of graft-versus-host disease Eur Cytokine Netw 21 1 40 49 10.1684/ecn.2009.0181 20146989 1:CAS:528:DC%2BC3cXjt12ju70%3D
78. J Catusse CM Parry DR Dewin UA Gompels 2007 Inhibition of HIV-1 infection by viral chemokine U83A via high-affinity CCR5 interactions that block human chemokine-induced leukocyte chemotaxis and receptor internalization Blood 109 9 3633 3639 10.1182/blood-2006-08-042622 17209056 10.1182/blood-2006-08-042622 1:CAS:528:DC%2BD2sXkvFCitrw%3D (Pubitemid 46641709)
79. Engelhardt BG, Crowe JE, Jr. (2010) Homing in on acute graft versus host disease: tissue-specific T regulatory and Th17 cells. Curr Top Microbiol Immunol 341:121-146. doi: 10.1007/82-2010-24
80. NA Kittan GC Hildebrandt 2010 The chemokine system: a possible therapeutic target in acute graft versus host disease Curr Top Microbiol Immunol 341 97 120 10.1007/82-2010-23 20379809 10.1007/82-2010-23 1:CAS:528: DC%2BC3cXhtlWhtLjP
81. GG Laport BM Sandmaier BE Storer BL Scott MJ Stuart T Lange MB Maris ED Agura TR Chauncey RM Wong SJ Forman FB Petersen JC Wade E Epner B Bruno WA Bethge PT Curtin DG Maloney KG Blume RF Storb 2008 Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders Biol Blood Marrow Transplant 14 2 246 255 10.1016/j.bbmt.2007.11.012 18215785 10.1016/j.bbmt.2007.11.012
82. C Roddie KS Peggs 2011 Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation Expert Opin Biol Ther 11 4 473 487 10.1517/14712598.2011.554811 21269237 10.1517/14712598.2011.554811
83. DI Marks R Lush J Cavenagh DW Milligan S Schey A Parker FJ Clark L Hunt J Yin S Fuller E Vandenberghe J Marsh T Littlewood GM Smith D Culligan A Hunter R Chopra A Davies K Towlson CD Williams 2002 The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation Blood 100 9 3108 3114 10.1182/blood-2002-02-0506 12384406 10.1182/blood-2002-02-0506 1:CAS:528:DC%2BD38XosVSis7k%3D (Pubitemid 35217056)
84. Y Fan W Weifeng Y Yuluan K Qing P Yu H Yanlan 2011 Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation Virol J 8 17 10.1186/1743-422X-8-17 21235788 10.1186/1743-422X-8-17
85. K Wilhelm J Ganesan T Muller C Durr M Grimm A Beilhack CD Krempl S Sorichter UV Gerlach E Juttner A Zerweck F Gartner P Pellegatti F Di Virgilio D Ferrari N Kambham P Fisch J Finke M Idzko R Zeiser 2010 Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R Nat Med 16 12 1434 1438 10.1038/nm.2242 21102458 10.1038/nm.2242 1:CAS:528:DC%2BC3cXhsVGhsr%2FL
86. Nakase H, Matsuura M, Uza N, Chiba T (2011) Tacrolimus suppresses IL-12/IL23 p40 in Crohn's disease and heals fistulae refractory to anti-TNF-alpha therapy. Aliment Pharmacol Ther 33 (8):979-980; author reply 980-981. doi: 10.1111/j.1365-2036.2011.04587.x
87. HC Van Zaanen HM Lokhorst LA Aarden HJ Rensink SO Warnaar MH Van Oers 1998 Blocking interleukin-6 activity with chimeric anti-IL6 monoclonal antibodies in multiple myeloma: effects on soluble IL6 receptor and soluble gp130 Leuk Lymphoma 31 5-6 551 558 10.3109/10428199809057614 9922045 (Pubitemid 29050596)
88. L Marti R Golmia AP Golmia AT Paes DD Guilhen CA Moreira-Filho M Scheinberg 2009 Alterations in cytokine profile and dendritic cells subsets in peripheral blood of rheumatoid arthritis patients before and after biologic therapy Ann NY Acad Sci 1173 334 342 10.1111/j.1749-6632.2009.04740.x 19758170 10.1111/j.1749-6632.2009.04740.x 1:CAS:528:DC%2BD1MXhtlCntr3F
89. P Quartier F Allantaz R Cimaz P Pillet C Messiaen C Bardin X Bossuyt A Boutten J Bienvenu A Duquesne O Richer D Chaussabel A Mogenet J Banchereau JM Treluyer P Landais V Pascual 2011 A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial) Ann Rheum Dis 70 5 747 754 10.1136/ard.2010.134254 21173013 10.1136/ard.2010.134254 1:CAS:528:DC%2BC3MXnt1egsLc%3D
90. JE Pease R Horuk 2009 Chemokine receptor antagonists: part 2 Expert Opin Ther Pat 19 2 199 221 10.1517/13543770802641353 19441918 10.1517/ 13543770802641353 1:CAS:528:DC%2BD1MXhsVCksr8%3D
91. JE Pease R Horuk 2009 Chemokine receptor antagonists: part 1 Expert Opin Ther Pat 19 1 39 58 10.1517/13543770802641346 19441897 10.1517/13543770802641346 1:CAS:528:DC%2BD1MXhsVyrtw%3D%3D
92. AE Proudfoot CA Power MK Schwarz 2010 Anti-chemokine small molecule drugs: a promising future? Expert Opin Investig Drugs 19 3 345 355 10.1517/13543780903535867 20113217 10.1517/13543780903535867 1:CAS:528:DC%2BC3cXhvFKmsrw%3D
93. T Yi Y Chen L Wang G Du D Huang D Zhao H Johnston J Young I Todorov DT Umetsu L Chen Y Iwakura F Kandeel S Forman D Zeng 2009 Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease Blood 114 14 3101 3112 10.1182/blood-2009-05-219402 19602708 10.1182/blood-2009-05-219402 1:CAS:528:DC%2BD1MXht12qur3J